Paper40337306
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment.
Del Bene A and 10 others. RSC Med Chem, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment. Papers, record 40337306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40337306
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References277
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8981914 | Induction of neonatal tolerance by plasmid DNA vaccination of mice. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8981914 | PubMed |
| 2 | 32728218 | An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. | Nature | 2020 | https://conductscience.org/library/papers/32728218 | PubMed |
| 3 | 36991248 | Staphylococcal enterotoxin B as DNA vaccine against breast cancer in a murine model. | Int Microbiol | 2023 | https://conductscience.org/library/papers/36991248 | PubMed |
| 4 | 19275763 | Role of 5'- and 3'-untranslated regions of mRNAs in human diseases. | Biol Cell | 2009 | https://conductscience.org/library/papers/19275763 | PubMed |
| 5 | 1545867 | Genetic immunization is a simple method for eliciting an immune response. | Nature | 1992 | https://conductscience.org/library/papers/1545867 | PubMed |
| 6 | 19809401 | A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs. | Mol Ther | 2010 | https://conductscience.org/library/papers/19809401 | PubMed |
| 7 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 8 | 30866759 | Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine. | Emerg Microbes Infect | 2019 | https://conductscience.org/library/papers/30866759 | PubMed |
| 9 | 26134983 | Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis. | Hum Exp Toxicol | 2016 | https://conductscience.org/library/papers/26134983 | PubMed |
| 10 | 34214046 | Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. | Science | 2021 | https://conductscience.org/library/papers/34214046 | PubMed |
| 11 | 28216575 | Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28216575 | PubMed |
| 12 | 34566407 | CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34566407 | PubMed |
| 13 | 25263094 | The ReNAissanCe of mRNA-based cancer therapy. | Expert Rev Vaccines | 2015 | https://conductscience.org/library/papers/25263094 | PubMed |
| 14 | 33879241 | Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation. | Genome Med | 2021 | https://conductscience.org/library/papers/33879241 | PubMed |
| 15 | 18797453 | Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. | Mol Ther | 2008 | https://conductscience.org/library/papers/18797453 | PubMed |
| 16 | 26323422 | Mucoadhesive Chitosan Derivatives as Novel Drug Carriers. | Curr Pharm Des | 2015 | https://conductscience.org/library/papers/26323422 | PubMed |
| 17 | 35365216 | Biological roles of RNA m5C modification and its implications in Cancer immunotherapy. | Biomark Res | 2022 | https://conductscience.org/library/papers/35365216 | PubMed |
| 18 | 16226783 | DNA immunization using a non-viral promoter. | Virology | 2006 | https://conductscience.org/library/papers/16226783 | PubMed |
| 19 | 30201512 | A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation. | Trends Microbiol | 2019 | https://conductscience.org/library/papers/30201512 | PubMed |
| 20 | 6247631 | 5'-terminal cap structure in eucaryotic messenger ribonucleic acids. | Microbiol Rev | 1980 | https://conductscience.org/library/papers/6247631 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40337306
GET https://conductscience.org/api/papers/v1/40337306/references?page=2